Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RACRc8X5dzqdlqSXGEK6CXvrpzW_1FDHV34sp5SfzO8ik#assertion>. }
Showing items 1 to 9 of
9
with 100 items per page.
- association type Statement assertion.
- association label ""* [see Drug Interactions ( 7 12.3 * LEXIVA is contraindicated when coadministered with the following drugs: o Alpha 1-adrenoreceptor antagonist: Alfuzosin o Antiarrhythmics: Flecainide (with ritonavir), propafenone (with ritonavir) o Antimycobacterial: Rifampin o Antipsychotic: Lurasidone (with ritonavir), pimozide o Ergot derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine o GI motility agent: Cisapride o Herbal product: St. John's wort ( Hypericum perforatum o Lipid modifying agents: Lomitapide, lovastatin, simvastatin o Non-nucleoside reverse transcriptase inhibitor: Delavirdine o PDE5 inhibitor: Sildenafil (REVATIO) (for treatment of pulmonary arterial hypertension) o Sedative/hypnotics: Midazolam, triazolam * 4 * 4 * 4"" assertion.
- association object DOID_10763 assertion.
- association predicate treats assertion.
- DOID_10763 category Disease assertion.
- drugbank:DB00701 category Drug assertion.
- association subject drugbank:DB00701 assertion.
- association provided_by NeuroDKG assertion.
- association relation MedicalContraindication assertion.